PROTOCOL NIDA-CTN-0048


Cocaine Use Reduction with Buprenorphine (CURB)

Walter Ling, MD
Lead Investigator
Director, Integrated Substance Abuse Programs, UCLA
lwalter@ix.netcom.com

Andrew Saxon, MD
Co-Lead Investigator

Director, Addiction Treatment Center
Veterans Affairs Puget Sound Health Care System
andrew.saxon@va.gov

Larissa Mooney, MD
Co-Lead Investigator
Integrated Substance Abuse Programs, UCLA
lmooney@mednet.ucla.edu

The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence. Eleven CTP study sites will enroll 300 cocaine-dependent participants who also meet criteria for either past-year opioid dependence or past-year opioid abuse, or past-year opioid use with a history of opioid dependence during the lifetime.

CTN-0048 Study Protocol

RELATED STUDIES
RELATED RESOURCES

snowflake

Publications about CTN-0048

Study data from NIDA Data Share

ClinicalTrials.gov (NCT01402492)

NIDA protocol page


NODES & CTPs SEARCH LINK
Pacific Region (Lead Node) search www
  Bay Area Addiction Research and Treatment (BAART) search www
  Integrated Substance Abuse Programs (ISAP), UCLA search www
Greater New York search www
Albert Einstein College of Medicine search www
Bellevue Hospital Center search www
Mid-Atlantic search www
Howard University search www
Ohio Valley search www
Maryhaven, Inc. search www
Pacific Northwest search www
Recovery Centers of King County search www
Southern Consortium search www
Atlanta VA Medical Center search www
Texas search www
VA South Texas Health Care System search www
Western States search www
Addiction Research & Treatment Services (ARTS) search
CODA, Inc. search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 10/2011 -- http://ctndisseminationlibrary.org/protocols/ctn0048.htm
info@ctndisseminationlibrary.org